文献速递肾癌与肾肿瘤

英格兰2000-2010年肾癌肾切除术服务供给与生存趋势

Time trends in service provision and survival outcomes for patients with renal cancer treated by nephrectomy in England 2000-2010.
PubMed 文献 · BJU Int · 2018-04-20

结果显示肾切除术数量增加66%,医院数量减少24%而医院年手术量中位数从10增至23,微创手术占比从1%升至46%,保留肾单位手术从5%升至16%。30天死亡率从2.4%降至1.1%,1年相对生存率从86.9%升至93.4%,5年相对生存率从68.2%升至81.2%。

要点

  • 肾切除术向大型医院集中,医院年手术量中位数从10增至23。
  • 微创手术占比从1%升至46%,保留肾单位手术从5%升至16%。
  • 30天死亡率从2.4%降至1.1%,5年相对生存率从68.2%升至81.2%。

核心结论

  • 肾癌手术治疗模式发生显著变化,表现为肾切除术集中化、保留肾单位手术和微创手术增加。
  • 短期和长期生存率均显著改善,老年患者和局部晚期患者获益最明显。

主要发现

  • 肾切除术年数量增加66%,医院数量减少24%,医院年手术量中位数从10增至23(P < 0.01)。
  • 外科医生数量增加27%(P < 0.01),每院顾问医师中位数翻倍。
  • 微创手术占比从1%升至46%,保留肾单位手术从5%升至16%,2010年29%的T1期患者接受部分肾切除术(P < 0.01)。
  • 30天死亡率从2.4%降至1.1%,90天死亡率从4.9%降至2.6%(P < 0.01)。
  • 1年相对生存率从86.9%升至93.4%,5年相对生存率从68.2%升至81.2%(P < 0.01)。

临床怎么用

  • 肾癌肾切除术应向高手术量医院集中,以改善短期和长期生存结局。
  • 在适用患者中应提高微创手术和保留肾单位手术的应用比例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe the temporal trends in nephrectomy practice and outcomes for English patients with renal cell carcinoma (RCC). PATIENTS AND METHODS: Adult RCC nephrectomy patients treated between 2000 and 2010 were identified in the National Cancer Data Repository and Hospital Episode Statistics, and followed-up until date of death or 31 December 2015 (n = 30 763). We estimated the annual frequency for each nephrectomy type, the hospital and surgeon numbers and their case volumes. We analysed short-term surgical outcomes, as well as 1- and 5-year relative survivals. RESULTS: Annual RCC nephrectomy number increased by 66% during the study period. Hospital number decreased by 24%, whilst the median annual hospital volume increased from 10 to 23 (P < 0.01). Surgeon number increased by 27% (P < 0.01), doubling the median consultant number per hospital. The proportion of minimally invasive surgery (MIS) nephrectomies rose from 1% to 46%, whilst the proportion of nephron-sparing surgeries (NSS) increased from 5% to 16%, with 29% of all T1 disease treated with partial nephrectomy in 2010 (P < 0.01). The 30-day mortality rate halved from 2.4% to 1.1% and 90-day mortality decreased from 4.9% to 2.6% (P < 0.01). The 1-year relative survival rate increased from 86.9% to 93.4%, whilst the 5-year relative survival rate rose from 68.2% to 81.2% (P < 0.01). Improvements were most notable in patients aged ≥65 years and those with T3 and T4 disease. CONCLUSIONS: Surgical RCC management has changed considerably with nephrectomy centralisation and increased NSS and MIS. In parallel, we observed significant improvements in short- and long-term survival particularly for elderly patients and those with locally advanced disease.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Hsu RCJ, Barclay M, Loughran MA, et al. Time trends in service provision and survival outcomes for patients with renal cancer treated by nephrectomy in England 2000-2010. BJU Int. 2018. PMID: 29603575. doi:10.1111/bju.14217

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。